Bio-analysis of docetaxel and hydroxylated metabolites in human plasma by high-performance liquid chromatography and automated

Journal of Chromatography B: Biomedical Applications

Volumn 696, Issue 1, 1997, Pages 89-98

  Rosing, H ^a   Lustig, V ^b   Koopman, F P ^a   Ten Bokkel Huinink, W W ^b   Beijnen, J H ^a,b,c  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Docetaxel

Indexed keywords

DOCETAXEL; DRUG METABOLITE;

ADULT; ARTICLE; AUTOMATION; BREAST CANCER; CASE REPORT; DRUG HYDROXYLATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PLASMA; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYDROXYLATION; LINEAR MODELS; METHANOL; MIDDLE AGED; OSMOLAR CONCENTRATION; PACLITAXEL; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TAXOIDS;

EID: 0030748742     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(97)00209-0     Document Type: Article

References (18)

1. M. Colin, D. Guénard, F. Guéritte-Voegelein, P. Potier, US Patent 4814470 (granted March 21; priority date, July 17, 1986).
2. M.T. Huizing, V.H. Sewberath Misser, R.C. Pieters, W.W. ten Bokkel-Huinink, C.H.N. Veenhof, J.B. Vermorken, H.M. Pinedo, J.H. Beijnen, Cancer Invest. 13 (1995) 381.
3. H. Burris, R. Irvin, J. Kuhn, S. Kalter, L. Smith, D. Schaffer, S. Fields, G. Weiss, J. Eckhardt, G. Roderiguez, D. Rinaldi, J. Wall, G. Cook, S. Smith, F. Vreeland, M. Bayssas, N. LeBail, D. Von Hoff, J. Clin. Oncol. 11 (1993) 950.
4. J.-M. Extra, F. Rousseau, R. Bruno, M. Clavel, N. LeBail, M. Marty, Cancer Res. 53 (1993) 1037.
5. B. Monegier, C. Gaillard, S. Sable, M. Vuilhorgne, Tetrahedron Lett. 35 (1994) 3715.
6. C. Gaillard, B. Monsarrat, M. Vuilhorgne, I. Royer, B. Monegier, S. Sable, D. Guénard, P. Gires, Y. Archimbaud, M. Wright, G.J. Sanderink, Proc. Am. Assoc. Cancer. Res. 35 (1994) 410.
7. J.C. Vergniol, R. Bruno, G. Montay, A. Frydman, J. Chromatogr. 582 (1992) 273.
8. A. Sparreboom, O. van Tellingen, E.J. Scherrenburg, J.J.B. Boesen, M.T. Huizing, W.J. Nooijen, C. Versluis, J.H. Beijnen, Drug Metab. Dispos. 24 (1996) 655.
9. D. Bissett, A. Setanoians, J. Cassidy, M.A. Graham, G.A. Chadwick, P. Wilson, V Auzannet, N. Le Bail, S.B. Kaye, D.J. Kerr, Cancer Res. 53 (1993) 523.
10. R. Pazdur, R.A. Newman, B.M. Newman, A. Fuentes, J. Benvenuto, B. Bready, D. Moore Jr., I. Jaiyesimi, F. Vreeland, M.M. Bayssas, J. Natl. Cancer Inst. 84 (1992) 1781.
11. H. Burris, R. Irvin, J. Kuhn, S. Kalter, L. Smith, D. Shaffer, S. Fields, G. Weiss, J. Eckardt, G. Rodriguez, J. Clin. Oncol. 11 (1993) 950.
12. J.M. Extra, F. Rousseau, R. Bruno, M. Clavel, N. Le Bail, M. Marty, Cancer Res. 53 (1993) 1037.
13. M.C. Launay-Iliadis, R. Bruno, V. Cosson, J.C. Vergniol, D. Oulid-Aissa, M. Marty, M. Clavel, M. Aapro, N. Le Bail, A. Iliadis, Cancer Chemother. Pharmacol. 37 (1995) 47.
14. E. Tomiak, M.J. Piccart, J. Kerger, S. Lips, A. Awada, D. de Valeriola, C. Ravoet, D. Lossignol, J.P. Sculier, V. Auzannet, J. Clin. Oncol. 12 (1994) 1458.
15. R. Bruno, G.J. Sanderink, Cancer Surv. 17 (1993) 305.
16. H.T. Karnes, C. March, J. Pharm. Biomed. Anal. 9 (1991) 911.
17. J.H. Proost, D.K.F. Meyer, Comput. Biol. Med. 22 (1992) 155.
18. V.P. Shah, K.K. Midha, S. Dighe, I.J. McGilveray, J.P. Skelly, A. Yacobi, T. Layloff, C.T. Viswanathan, C.E. Cook, R.D. McDowall, K.A. Pittman, S. Spector, J. Pharm. Sci. 81 (1992) 309.